STANDARD OPERATING PROCEDURES DIVISION OF COMPARATIVE MEDICINE UNIVERSITY OF SOUTH FLORIDA

Similar documents
GUIDELINES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH MICHIGAN STATE UNIVERSITY ENVIRONMENTAL HEALTH AND SAFETY

Study Files and Filing

DRUG ORDERING AND MAINTENANCE

Standard Operating Procedures Guidelines for Good Clinical Practice

Human Research Protection Program Good Clinical Practice Guidance for Investigators Regulatory File Essential Documents

IMP Management and Accountability

TITLE: Research Pharmacy Standard Policy SOP #: INV-100 Page: 1 of 5 Effective Date: 8/31/17

IND Drug Log Guidelines

STANDARD OPERATING PROCEDURES DIVISION OF COMPARATIVE MEDICINE UNIVERSITY OF SOUTH FLORIDA

Standard Operating Procedure. Handling of Radioactive Material. PC-SOP-IM-005-v02

Quality Assurance QA STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits

Guidance for Industry - Computerized Systems Used in Clinical Trials

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

SECTION 6.2: CONTRACT MANAGER

MEDICAL NITROUS OXIDE AND ENTONOX COMPLIANCE

Trial Master File / Investigator Site File Index Clinical Trials of Investigational Medicinal Products

ISRCTN: EudraCT Number: Sponsor Protocol Number: UCL 08/0350. Pharmacy Manual

Policy and Procedure Manual

University of Maryland Baltimore. Radiation Safety Procedure

Source Documents and Regulatory Binders October 6, 2016

Manage Deliverables - Construction Step 6 February 2015

OECD and EPA GLP Differences

March 2013 I-9 EMPLOYMENT ELIGIBILITY VERIFICATION

Vaccine Management Plan

Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework

Presentation of Capabilities Reverse Logistics

The interface between Good Clinical Practice and Good Manufacturing Practice

Radiation Safety Committee Control Functions and Administrative Procedures

Healthcare Waste Regulatory Challenges. Selin Hoboy November 17, 2011

LABORATORY SAFETY EVALUATION. S = Satisfactory N = Needs Improvement* N/A = Not Applicable

Theodore Sullivan Partner Quarles & Brady LLP (Washington, DC)

Vertebrate Animal Use Protocol for Research or Testing

Microsphere Brachytherapy Sources and Devices

COMPLETE COMPLIANCE CHECKLIST

EASTERN MICHIGAN U N I V E R S I T Y SECURITY OF HAZARDOUS MATERIALS IN TRANSPORT

IACUC THE UNIVERSITY OF PITTSBURGH LEADER IN EDUCATION PIONEER IN RESEARCH PARTNER IN REGIONAL DEVELOPMENT

NORTH CAROLINA VETERINARY MEDICAL BOARD PRACTICE INSPECTION 1611 Jones Franklin Road, Suite 106, Raleigh NC (919) FAX (919)

R&D Manager Hillingdon Hospital. Revision History Effective Date Reason For Change. recommendations Version no:

Appendix D. Living Marine Resources Program Ocean Observing System Notification Procedures

Author Signature: Date: 10 October 2017 The author is signing to confirm the technical content of this document

PRINCIPAL INVESTIGATOR MANUAL

Radiation Safety Policy & Procedures

Guidelines for Developing Randomization Procedures R03

APPLICATION for LICENSE WHOLESALE DISTRIBUTOR of LEGEND DRUGS or DEVICES

Title: Leave Share Policy. Revision Date: First Version Page: 1 of 5 I. SCOPE

National Institute of Allergy and Infectious Diseases National Institutes of Health Department of Health and Human Services

Objectives. The Regulatory Binder = Investigator Site File= Trial Center File 8/16/2010. Essential Documents: Maintaining the Site's Regulatory Binder

Institutional Biosafety Committee

Rev A. Vendor Compliance Manual

Hazard Communication Program. University of San Diego

The transition to OptumRx is designed to help us better serve your employees and help improve their overall experience:

1 The Clinical Research Coordinator (CRC)... 1

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria

Investigator Manual. Human Subjects Protection Program

Managing a Research Team. Mandy Morneault Manager, Research Coordinator Core ITHS Clinical Services

Investigator-Initiated INDs

SECTION I CITIZENSHIP: CITIZENSHIP: SECTION II

*NOTIFY THE DEPARTMENT IN WRITING OF ANY UPDATES

FAIRCHILD APPLICATION FOR EMPLOYMENT

BOWDOIN COLLEGE BIOMEDICAL WASTE MANAGEMENT PLAN

The School Board of Broward County, Florida Treasurer s Office 7720 West Oakland Park Blvd. Suite 319 Sunrise, FL

Quality Management System

Hazardous Waste Generator Improvements Rule

Research Job Summaries

ZOLL Document Number: 90E0004 Page 5 of 15 Maintenance of Quality Records

Ch. 463a POSSESSION OF SLOT MACHINES a.1. CHAPTER 463a. POSSESSION OF SLOT MACHINES AND FULLY AUTOMATED ELECTRONIC GAMING TABLES

GCP Basics - refresher

APPLICATION FOR EMPLOYMENT

November 12, The Law of Islamic Republic of Afghanistan Draft Law on Industrial Designs

State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics

CONSERVATION VOLUNTEERS

SOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS

Introduction to Clinical Research

INVESTIGATIONAL DRUG SERVICE (IDS) Standard Operating Procedures

Clinical Trials and the Code of Federal Regulations. Darlene Kitterman, MBA Director, Investigator Support & Integration Services September 24, 2014

GUIDE TO SMALL BUSINESS RECORDKEEPING. To make your business #CPAPOWERED, call today and let s get started.

Radiation Protection Program Updates

Standard operating procedure

UCLA Procedure 615.1: Employee Driving Records

Director of Evaluation and Licensing Division Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare

EMPLOYEE RIGHTS AND RESPONSIBILITIES UNDER THE FAMILY AND MEDICAL LEAVE ACT

New York University Institutional Biosafety Policy Updated 08/03/2015

Guidelines for Laboratory Closure

Operating Room Manual

FDA Audit Preparation

Rule Business Function Retention Rule Title Retention Period Description

First and Second-Line Supervisor Tests Test Security Agreement and Order Form

Preparing for Close-Out of Studies and Sites

Regulated Medical Waste Management and Proper Waste Segregation. State-Specific Information Florida

Purpose. Scope and restrictions. Responsibilities. Faculty of Health and Wellbeing Biosciences STANDARD OPERATING PROCEDURE.

Pharma and Logistic Service Providers (LSP) Synergies and opportunities GDP, NEW EUROPEAN DIRECTIVES

Presentation to the Long Island Import Export Association Export Compliance Due Diligence, Regulations & Responsibilities

Name . Address Street City State/Zip Code. Telephone ( ) Mobile /Other Phone ( )

Explanatory Note for Pharmacists, on the Supply of Emergency Prescription-Only Medicines to a Listed Organisation

Institutional Biosafety Committee

Multi-Site Coordination Process. Drafted by: Ester Dimayuga Page 1 of 18

Report No. DODIG May 7, Additional Guidance and Training Needed to Improve Afghan National Army Pharmaceutical Distribution

Hazardous Inventory Tracking System (HITS) Tutorial

Strasser, Jane (strassje)

PERSONAL DATA Last Name: First: Middle: Today s Date: City: State: ZIP: Primary Telephone: Secondary Telephone: Address:

Transcription:

STANDARD OPERATING PROCEDURES DIVISION OF COMPARATIVE MEDICINE UNIVERSITY OF SOUTH FLORIDA SOP#: 014.5 Date Issued: 11/00 Date Revised: 8/15 Page 1 of 5 TITLE: SCOPE: RESPONSIBILITY: PURPOSE: Research and Animal Program Personnel Research Coordinator, Veterinary Care Manager, Facility Managers, and All Animal Program Personnel To Outline the Program of I. PURPOSE 1. To establish appropriate procedures for procurement, distribution, use, record keeping, and disposal of controlled substances used in research and teaching protocols. II. RESPONSIBILITY 1. It is the responsibility of the Assistant Director to administer the Controlled Substance Program for the University of South Florida. The Assistant Director receives the controlled substance(s), maintains the Master Log, disperses to Facility Managers, conducts biennial inventories, and administers the final closeout/disposal of all controlled substances. 2. The Assistant Director is responsible for maintaining records of certification of all principal investigators (PI) and their designated research staff using controlled substances at the University of South Florida. 3. Facility Managers are responsible for dispensing controlled substances and maintaining records of all controlled substance use associated with the facility they manage. III. POLICY 1. University policies regarding procurement, distribution, use, security, and recordkeeping of controlled substances regulated by the Drug Enforcement Administration (DEA) are guided by the regulations detailed in 21 CFR 1300-1308. 2. Any faculty member requesting, possessing, or using any controlled substance in research or teaching must be registered with the Division of Comparative Medicine, c/o the Assistant Director at MDC 20, phone 974-9876, or fax 974-9432. 3. Registrants must be faculty members and are responsible for all aspects of this policy. Registrants must identify the controlled substance(s) used in an approved IACUC protocol or an Application for the Use of in Research Not Involving Animals, the individual(s) responsible for assisting in their

Page 2 of 5 compliance with these policies, and the location where the controlled substance will be securely stored, and they must ensure that complete records will be maintained. Faculty must ensure controlled substances are stored in an area of limited access securely locked in a substantially constructed cabinet. Controlled substances must be secured behind two locks. Laboratory doors can be considered one lock, if doors of unattended labs are kept locked. 4. Registered faculty must procure all controlled substances from the Division of Comparative Medicine. Controlled substance distribution to faculty located at the Byrd Alzheimer s Institute, College of Medicine, J.A. Haley V.A. Hospital, Psychology CSD, College of Public Health, Interdisciplinary Research Building, College of Arts & Sciences, Stabile Research Building, and satellite facilities are made through the Facility Managers at those locations. 5. The University holds and recognizes two institutional DEA registrations for basic and preclinical research protocols (i.e., a Schedule I and a Schedule II-V registration), with the Director of Comparative Medicine as the institutional licensee. All other registrations are in violation of University policy and must be surrendered to the Division of Research Integrity & Compliance, 974-5638. 6. Each vial of controlled substance procured under the University s institutional DEA licenses is assigned a unique identifying code that corresponds to that substance s Schedule, Federal Drug Code number, and a consecutive vial inventory number. 7. The Division of Comparative Medicine maintains records of all controlled substance distributions to Principal Investigators. These records consist of a chronological log of all controlled substance dispersals indexed by substance and principal investigator. 8. Request for controlled substances must be submitted in writing to the appropriate Facility Manager using the Supplies, Equipment, and Services order form (CMDC #107) at least 24 hours prior to being dispensed. 9. Additional requests for a controlled substance can only be filled when the status of the previous dispersal has been verified with the appropriate Facility Manager. 10. Principal Investigators are responsible for maintaining accurate records of controlled substances used while in their possession by recording, on the Controlled Substance Record of Use Log, the amount used and the amount remaining in each vial. 11. Principal Investigators are responsible for returning the signed Controlled Substance Record of Use Log to the Division of Comparative Medicine when their inventory is depleted. Any unused controlled substance, a controlled substance associated with a completed protocol, or an out-of-date controlled substance must be returned to the Division of Comparative Medicine. 12. Laboratories, storage cabinets, logs of use, and inventory records are subject to unannounced inspections and audits by the DEA, Division of Research Integrity & Compliance, and Division of Comparative Medicine. 13. Non-compliance can result in suspension of privileges to use controlled substances.

Page 3 of 5 IV. PROCEDURES 1. Procedures for receiving and dispersing controlled substances: a. The Assistant Director is responsible for receiving all controlled substances from outside vendors. b. Requests for controlled substances by research staff are made through the appropriate Facility Manager in writing using the Supplies, Equipment and Services order form (CMDC #107). c. When controlled substances arrive, they are checked and approved by the Assistant Director and then assigned a unique identifying code that corresponds to that substance s schedule number, Federal Drug Code number, and a consecutive vial inventory number. d. The controlled substance is then entered on the Controlled Substance Master Inventory, listing: 1. the unique substance identification number 2. substance name 3. source 4. 222 number (Schedule I & II substances only)) 5. amount received 6. date received 7. received by e. Controlled substances are dispersed to Facility Managers and are tracked by entering the following information on the Controlled Substance Master Inventory, 1. dispersal date 2 dispersed by 3. dispersed to 4. expiration date of substance 2. Procedures for managers receiving dispersed controlled substances: a. Controlled substances are dispersed from the Assistant Director to a Facility Manager and are tracked by entering the following information on the Controlled Substance Facility Inventory-Substance log (indexed by substance name): 1. Unique substance identification number 2. Date received 3. Amount received 4. Date of expiration 3. Procedures for research staff requesting controlled substances: a. Faculty, having completed the process of registration and certification, can order controlled substances only when described in their approved IACUC protocol(s) or, if controlled substance use in research does not involve animals, in an Application for the Use of in Research Not Involving Animals by placing an order with the appropriate Facility Manager. b. Requests for controlled substances must be submitted in writing using the Supplies, Equipment and Services order form (CMDC #107). Although many commonly requested drugs are stocked in the pharmacy, requests should be made in advance of an anticipated need to insure availability. Additional time should be allotted for any unique substances that need to be ordered or for the request of Schedule I and II controlled substances not currently described on the University s registration to allow for amending the registration prior to being ordered. c. Completed order forms may be submitted via campus mail, fax, e-mail, or hand delivered to the appropriate manager.

Page 4 of 5 d. Prior to filling an order, the Manager ensures the PI s Certification of Research Personnel Using is current and that the certification form adequately describes: the personnel requesting and using the controlled substance, and the location where the substances will be secured. The Manager then reviews the IACUC protocol referenced on the order form or the Application for the Use of a Controlled Substance in Research Not Involving Animals to determine if the controlled substance is described within. Finally, the Controlled Substance/Facility Inventory is reviewed to determine if all prior dispersals have been accounted for. e. A controlled substance may be dispensed only when all the above requirements have been met. The PI will be notified when their order is available to be picked up at the facility s pharmacy. 4. Procedures for dispensing controlled substances: a. A controlled substance is dispensed by locating its unique identification number in the Controlled Substance Facility Inventory-Substance log and adding the following information: 1. Date dispensed 2. PI issued to b. The controlled substance being dispensed is similarly tracked by entering the following information on the Controlled Substance Facility Inventory-PI log (indexed by principal investigator): 1. Unique substance identification number 2. Substance name 3. Date dispensed 4. Amount dispensed 5. Date expires 6. IACUC number 8. Individual dispensed to and initials 9. Phone # 10. Storage location where substance is secured c. A controlled substance Record of Use Log is filled out and issued with every controlled substance being dispensed and includes the following information: 1. Name of substance 2. Unique identification number 3. Date issued 4. Principal investigator 5. IACUC or CS number 6. Name & signature of recipient 7. Telephone number of laboratory where used 8. Location where drug will be securely stored 9. Volume received 10. Date of expiration 11. Issuing facility d. When both Controlled Substance Facility Inventory records are completed (one indexed by substance and one by PI), the Record of Use Log issued, and the person receiving the drugs has signed for them, the drugs may be dispensed. e. Additional controlled substance cannot be dispensed until the status of the previously dispensed substance has been determined.

Page 5 of 5 5. Procedures for maintaining the Controlled Substance Record of Use Log: a. The Record of Use Log should be kept in a secure place, preferably stored with the controlled substance. b. Each time the controlled substance is used, the date, the volume removed from the vial, the initials of the person removing it, and the balance remaining in the vial is recorded on the Record of Use Log. c. When the vial of controlled substance is depleted, the PI signs the log confirming that the log accurately reflects the usage and returns it to the appropriate Comparative Medicine Facility Manager. 6. Procedure for conducting the closeout of a controlled substance: a. The PI completes the Record of Use Log, signs it, and returns it to the appropriate Manager to close out their use. b. The Manager enters the date the Record of Use Log is received on the top of the form and on the Controlled Substance Facility Inventory-PI log form to close out their dispensation. Once checked in, the Record of Use Log is submitted to the Assistant Director. c. The Assistant Director enters the date the Record of Use Log is returned on the Controlled Substance Master Inventory to close out the dispersal inventory records. Record of Use Logs are filed numerically. 7. Any controlled substance that becomes outdated, is no longer in use, or is associated with a completed protocol will be returned, with the Record of Use Log, to the appropriate Manager for proper storage or disposal and closeout. 8. Audits and inspections of Controlled Substance procurement, dispersal, use, storage, and recordkeeping may be conducted, unannounced, by the DEA, Division of Research Integrity & Compliance, and Division of Comparative Medicine. 9. Audits and inspections of individual investigator s laboratories and Record of Use Logs are conducted jointly by Division of Research Integrity & Compliance and the Division of Comparative Medicine. 10. At least every two years, the registrant (i.e., Comparative Medicine) shall take a new inventory of all stocks of controlled substances on hand as required by 21 CFR Section 1304.11. This biennial inventory may be taken on any date which is within two years of the previous biennial inventory date. 11. Access to controlled substances within the animal facility is limited to: a. Clinical Veterinarians have keys to the College of Medicine facility dispensing cabinet. b. All Facility Managers have keys to the dispensing cabinets located within their facility. c. The Assistant Director for Administrative Services and the Assistant Director for Regulatory Affairs have keys to the Master Inventory Cabinet located at the College of Medicine. Approved: Date: